T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival

T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival

Perioperative chemotherapy enhances the survival rates for patients with esophageal and gastric (EG) adenocarcinoma, but not all patients benefit from this additional treatment. Chemotherapeutic agents have been demonstrated to alter the immune cell (IC) composition in the tumor microenvironment. He...

Full description

Bibliographic Details
Main Authors: Maria Christina Svensson, Albin Lindén, Jakob Nygaard, David Borg, Charlotta Hedner, Björn Nodin, Karin Leandersson, Karin Jirström
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:OncoImmunology
Subjects:
esophageal cancer
gastric cancer
neoadjuvant chemotherapy
t-cells
b-cells; pd-l1 expression
Online Access:http://dx.doi.org/10.1080/2162402X.2021.1921443

Internet

http://dx.doi.org/10.1080/2162402X.2021.1921443

Similar Items